New results from a clinical trial reveal that a single dose of psilocybin — a naturally occurring psychedelic compound found in mushrooms — can provide sustained reductions in depression and anxiety in individuals with cancer suffering from major depressive disorder. The findings are published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society.
People with cancer often struggle with depression. In this phase 2 trial, 28 patients with cancer and major…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply